March 24, 2026 · Form 4 insider transaction
Schneyer Mark C. bought 8,138 shares of ACADIA Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.